Pages that link to "Q52698622"

The following pages link to Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age. (Q52698622):

Displaying 32 items.

• Dietary interventions for phenylketonuria (Q24240788) (← links)
• Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria (Q33832790) (← links)
• Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria (Q35079956) (← links)
• Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria (Q35258165) (← links)
• Intelligence and quality of dietary treatment in phenylketonuria (Q35624913) (← links)
• Neurodevelopmental and Cognitive Outcomes of Classical Homocystinuria: Experience from Qatar (Q35752496) (← links)
• Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria (Q36110718) (← links)
• Executive function in adolescents with PKU and their siblings: Associations with biochemistry (Q36571585) (← links)
• Non-PKU mild hyperphenylalaninemia (MHP)--the dilemma (Q37883710) (← links)
• Psychiatric symptoms in adults with phenylketonuria. (Q38075927) (← links)
• Metabolic syndromes with dermatologic manifestations (Q39731458) (← links)
• Screening for metabolic disorders. How are we doing? (Q40866260) (← links)
• Mental retardation: genetic findings, clinical implications and research agenda (Q40948467) (← links)
• Birth weight and pathogenesis in phenylketonuria (Q41216214) (← links)
• Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). (Q42967337) (← links)
• Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU). (Q42967340) (← links)
• Bony changes of PKU neonates unrelated to phenylalanine levels (Q43486163) (← links)
• Results of psychological testing of patients aged 3-6 years (Q44618268) (← links)
• Executive function impairment in early-treated PKU subjects with normal mental development. (Q44908096) (← links)
• Phenylketonuria Scientific Review Conference: state of the science and future research needs (Q45298394) (← links)
• Host conditioning and rejection monitoring in hepatocyte transplantation in humans (Q47906882) (← links)
• Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats (Q48028295) (← links)
• Interhemispheric transfer in children with early-treated phenylketonuria. (Q48116826) (← links)
• Lateralized deficits in visual attention in males with developmental dopamine depletion (Q48495304) (← links)
• Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study (Q50966161) (← links)
• Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study (Q51900571) (← links)
• Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria (Q61908599) (← links)
• Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta-analysis of randomized controlled trials (Q64078924) (← links)
• Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria (Q70566130) (← links)
• Personality disorder in young women with treated phenylketonuria (Q72476137) (← links)
• Phenylketonuria and some aspects of emotional development (Q72508004) (← links)
• Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches (Q91575116) (← links)